tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Novartis: Strong Performance and Strategic Initiatives Justify Buy Rating
PremiumRatingsNovartis: Strong Performance and Strategic Initiatives Justify Buy Rating
6d ago
Trump says drug tariffs probable by August 1, semis coming soon, Bloomberg says
Premium
The Fly
Trump says drug tariffs probable by August 1, semis coming soon, Bloomberg says
7d ago
Novartis loses bid to block MSN generic of Entresto, Bloomberg says
Premium
The Fly
Novartis loses bid to block MSN generic of Entresto, Bloomberg says
12d ago
Novartis announces Coartem Baby approved by Swissmedic
PremiumThe FlyNovartis announces Coartem Baby approved by Swissmedic
15d ago
GSK completes acquisition of efimosfermin alfa from Boston Pharmaceuticals
Premium
The Fly
GSK completes acquisition of efimosfermin alfa from Boston Pharmaceuticals
16d ago
Novartis reports GCAptAIN study did not meet primary endpoint
Premium
The Fly
Novartis reports GCAptAIN study did not meet primary endpoint
20d ago
Trump administration weighs crackdown on pharma ads, Bloomberg says
PremiumThe FlyTrump administration weighs crackdown on pharma ads, Bloomberg says
1M ago
Senators to propose ban on drug ads to consumers, WSJ reports
Premium
The Fly
Senators to propose ban on drug ads to consumers, WSJ reports
1M ago
Novartis announces results from APPULSE-PNH study of Fabhalta
Premium
The Fly
Novartis announces results from APPULSE-PNH study of Fabhalta
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100